Executive record
Liisa Bayko
Most recent record: Kalaris Therapeutics, Inc. appoints Liisa Bayko as CFO (named as the incoming officer), effective July 20, 2026. See Kalaris Therapeutics, Inc..
1 verified record
This page lists only verified filing records that name Liisa Bayko; it is not a career history. Corrections: the corrections page.